© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Author | Michaela J. Higgins, MRCPI
Articles
New Directions in the Systemic Treatment of Metastatic Thyroid Cancer
August 14, 2009
About 30,000 new cases of thyroid cancer are diagnosed annually in the United States.[1] The incidence among men has risen more dramatically than any other malignancy in recent years (2.4% annual increase).[2] Thyroid cancers arise from one of two cell types, namely follicular and parafollicular cells.
Adjuvant Endocrine Therapy for Premenopausal Hormone Receptor–Positive Breast Cancer: Much Done, More to Do
January 02, 2009
Based on the 1995 Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) Overview, tamoxifen is now the standard of care for premenopausal women with hormone receptor–positive early breast cancers.[1]
Therapeutic Options in the Management of Metastatic Breast Cancer
May 01, 2008
Novel agents are adding to the wide choices of standard chemotherapies already available. This review offers an approach to the selection of individualized and rational therapies for patients with metastatic breast cancer.